Ionis Pharmaceuticals, Inc., announced, that Kyle Jenne has rejoined Ionis as executive vice president, chief global product strategy officer, to lead all aspects of...
Ionis Pharmaceuticals, Inc. announced that its partner Biogen has received U.S. Food and Drug Administration (FDA) approval of QALSODY 100 mg/15mL injection for the...
Ionis Pharmaceuticals, Inc. announced positive topline results from a 35-week interim analysis of the Phase 3 NEURO-TTRansform study of Ionis and AstraZeneca's eplontersen in...
